INCY|Analyst Targets
INCY|Company Info
INCY|Insider Trading
INCY|Fundamentals
INCY|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-3.70 | - | - |
| Q2'26 | $2.15 | $3.09 | +43.9% |
| Q1'26 | $1.34 | $1.81 | +35.1% |
| Q4'25 | $1.57 | $1.80 | +14.8% |
| Q3'25 | $1.64 | $2.26 | +38.0% |
| Q2'25 | $1.47 | $1.57 | +6.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.5B | - | - |
| Q2'26 | $1.5B | $1.7B | +11.4% |
| Q1'26 | $1.2B | $1.3B | +5.1% |
| Q4'25 | $1.3B | $1.5B | +20.5% |
| Q3'25 | - | $1.4B | - |
| Q2'25 | - | $1.2B | - |
INCY|Monthly Returns
Market Data
INCY Stock Snapshot
- Market cap
- 22.01B
- P/E ratio
- 13.7
- Day range
- $107.83 – $112.06
- News sentiment
- 58/100 · Neutral
- Analyst target
- $129.54 (+16.1%)
- Consensus
- Hold · 37 analysts
The signal on INCY is bullish: price action is confirming the underlying trend, not fighting it. In Healthcare, names this size usually take direction from sector flows before company-level news.
Behaviour On Record
What INCY's own history says about today's numbers
- Realized volatility (21d)
- 29.8% 33rd pct
- Below its peak
- -28.3%
- vs 200-day average
- +1.4%
- Up days (1y)
- 50%
Incyte Corporation is currently running 29.8% annualised volatility over the last 21 sessions. Measured against INCY's own 13 years of daily returns rather than a market-wide average, that is the 33rd percentile — on the quiet side for this stock, against a typical reading of 34.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
INCY is trading -28.3% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -32.2%, and the deepest was -42.6% in 2018. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +1.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 49th percentile — close to the gap it normally carries. Over the past year INCY closed higher on 50% of sessions, and it is currently 2 sessions into a falling streak.
On October specifically: over 13 years of records, INCY finished the month higher 6 of 13 times, with a median return of -0.3% and an average of +4.1%. Its strongest month historically has been October at +4.1% on average, its weakest September at -4.6%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: INCY has opened more than 2% away from the prior close in 219 of 3,267 sessions (6.7% of the time), with the largest gaps running +10.7% and -19.3%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, INCY moved an average of 1.6% in the session after earnings, closing higher 1 of those 3 times, with a median move of -0.6% and a largest of -2.2%.
All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against INCY's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of INCY's sector?
Incyte Corporation sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, INCY ranks 9th of 15 tracked industries, improving.
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
- Industry rank
- #9 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on INCY?
Truist Securities most recently reiterated its rating on Incyte Corporation to Hold on Oct 14, 2026 with a price target of $115 (from $105). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Truist Securities — Hold
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
INCY peers & ETF holders
BiotechnologyMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | ▼ Sell | 18,032,718 | 8.90% | $2.04B | 2026-08-07 |
| Vanguard Group Inc | ▼ Sell | 19,911,434 | 9.83% | $1.97B | 2026-01-29 |
| AQR Capital Management LLC | ▼ Sell | 5,320,901 | 2.63% | $603.18M | 2026-08-14 |
| Geode Capital Management, LLC | ▲ Buy | 4,750,735 | 2.34% | $536.52M | 2026-08-12 |
| Invesco Ltd. | ▲ Buy | 4,080,461 | 2.01% | $462.56M | 2026-08-14 |
| Wellington Management Group LLP | ▲ Buy | 3,575,521 | 1.76% | $405.32M | 2026-08-14 |
| Renaissance Technologies LLC | ▼ Sell | 3,512,132 | 1.73% | $398.14M | 2026-08-13 |
| Morgan Stanley | ▲ Buy | 2,948,364 | 1.46% | $334.23M | 2026-08-13 |
| Goldman Sachs Group Inc | ▼ Sell | 2,305,782 | 1.14% | $261.38M | 2026-08-14 |
| Two Sigma Investments, LP | ▲ Buy | 2,003,559 | 0.99% | $227.12M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 1,761,966 | 0.87% | $199.74M | 2026-08-13 |
| FMR LLC (Fidelity) | ▲ Buy | 1,381,773 | 0.68% | $156.64M | 2026-08-13 |
| Marshall Wace, LLP | ▲ Buy | 1,310,154 | 0.65% | $148.52M | 2026-08-13 |
| Norges Bank | ▼ Sell | 1,119,107 | 0.55% | $126.86M | 2026-08-12 |
| Man Group plc | ▲ Buy | 952,941 | 0.47% | $108.03M | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 761,690 | 0.38% | $87.34M | 2026-08-12 |
| Gotham Asset Management, LLC | ▲ Buy | 719,545 | 0.36% | $81.57M | 2026-08-14 |
| Bank of America Corp | ▼ Sell | 676,191 | 0.33% | $76.65M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 586,431 | 0.29% | $66.48M | 2026-08-03 |
| Wells Fargo & Company | ▲ Buy | 255,064 | 0.13% | $28.91M | 2026-08-14 |
| Winton Group Ltd | ▲ Buy | 254,408 | 0.13% | $28.84M | 2026-08-07 |
| Prudential Financial Inc | ▼ Sell | 191,312 | 0.09% | $21.69M | 2026-08-12 |
| Bridgewater Associates, LP | ▲ Buy | 168,253 | 0.08% | $19.07M | 2026-08-14 |
| AllianceBernstein L.P. | ▲ Buy | 201,209 | 0.10% | $18.94M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 143,509 | 0.07% | $16.27M | 2026-09-02 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-05-15 | 2025-05-31 |
| Shelley Moore Capito | Senate | WV | ▼ Sell | $1K - $15K | 2018-11-12 | 2018-12-08 |
| Shelley Moore Capito | Senate | WV | ▲ Buy | $1K - $15K | 2017-09-08 | 2017-10-06 |